Invention Grant
US07834163B2 Prostate specific genes and the use thereof as targets for prostate cancer therapy
失效
前列腺特异性基因及其作为前列腺癌治疗靶标的用途
- Patent Title: Prostate specific genes and the use thereof as targets for prostate cancer therapy
- Patent Title (中): 前列腺特异性基因及其作为前列腺癌治疗靶标的用途
-
Application No.: US10560723Application Date: 2004-06-25
-
Publication No.: US07834163B2Publication Date: 2010-11-16
- Inventor: Richard Einstein , Kevin M. McGowan , Matthew P. Pando
- Applicant: Richard Einstein , Kevin M. McGowan , Matthew P. Pando
- Applicant Address: FR Paris
- Assignee: Exonhit Therapeutics S.A.
- Current Assignee: Exonhit Therapeutics S.A.
- Current Assignee Address: FR Paris
- Agency: Nixon & Vanderhye P.C.
- International Application: PCT/IB2004/002394 WO 20040625
- International Announcement: WO2004/113571 WO 20041229
- Main IPC: C07H21/02
- IPC: C07H21/02
Abstract:
Genes that are upregulated in human prostate tumor tissues and the corresponding proteins are identified. These genes and the corresponding antigens are suitable targets for the treatment, diagnosis or prophylaxis of prostate cancer.
Public/Granted literature
- US20060115821A1 Prostate specific genes and the use thereof as targets for prostate cancer therapy Public/Granted day:2006-06-01
Information query
